Duchenne and becker muscular dystrophy: Contribution of a molecular and immunohistochemical analysis in diagnosis in Morocco

16Citations
Citations of this article
70Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are X-linked recessive disorders caused by mutations of the DMD gene located at Xp21. In DMD patients, dystrophin is virtually absent; whereas BMD patients have 10% to 40% of the normal amount. Deletions in the dystrophin gene represent 65% of mutations in DMD/BMD patients. To explain the contribution of immunohistochemical and genetic analysis in the diagnosis of these dystrophies, we present 10 cases of DMD/BMD with particular features. We have analyzed the patients with immunohistochemical staining and PCR multiplex to screen for exons deletions. Determination of the quantity and distribution of dystrophin by immunohistochemical staining can confirm the presence of dystrophinopathy and allows differentiation between DMD and BMD, but dystrophin staining is not always conclusive in BMD. Therefore, only identification involved mutation by genetic analysis can establish a correct diagnosis. Copyright © 2009 Hanane Bellayou et al.

Cite

CITATION STYLE

APA

Nadifi, S., Bellayou, H., Hamzi, K., Rafai, M. A., Karkouri, M., Slassi, I., & Azeddoug, H. (2009). Duchenne and becker muscular dystrophy: Contribution of a molecular and immunohistochemical analysis in diagnosis in Morocco. Journal of Biomedicine and Biotechnology, 2009. https://doi.org/10.1155/2009/325210

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free